3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
8
Uterine Cervical Neoplasms
6
Carcinoma, Renal Cell
5
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Colonic Neoplasms
4
Sarcoma
3
Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Hodgkin Disease
3
Breast Neoplasms, Male
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Liver Neoplasms
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Adenocarcinoma, Follicular
2
von Hippel-Lindau Disease
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Interventions
pazopanib
4
tazemetostat
3
Doxorubicin
3
cixutumumab
2
Sorafenib
2
Radiotherapy
2
Radiation
2
Interferon-gamma
2
Ifosfamide
2
Gemcitabine
2
tremelimumab
1
temsirolimus
1
sapanisertib
1
romidepsin
1
pembrolizumab
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
interferon gamma-1b
1
indolepropanol phosphate
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sunitinib
1
Rifampin
1
Razoxane
1
Ramucirumab
1
Radiotherapy, Conformal
1
Observation
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Synovial
×
Fluorodeoxyglucose F18
×
Clear all
No trials found.